SUZHOU, China and NEW YORK, May 20, 2019 /PRNewswire/ — CMAB Biopharma Limited. (CMAB), a strict “pure-play” contract development and manufacturing organization (CDMO) focusing solely on services from sequence to commercial manufacturing for biologic products, has today announced […]